Invesco Biotechnology & Genome ETF (PBE) Investment Research Dashboard
About Invesco Biotechnology & Genome ETF (PBE) stock analysis
Get live PBE stock price $91.70, comprehensive Invesco Biotechnology & Genome ETF stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time PBE stock data and investment insights.
Loading chart data...
Invesco Biotechnology & Genome ETF (PBE) Overview
Invesco Biotechnology & Genome ETF (PBE) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, PBE trades at $91.70 with a market capitalization of 284.56M . Over the past 52 weeks, PBE has traded between $64.60 and $94.06 , with the current price positioned at approximately 92% of this range . The s...
Key Takeaways
- Operates in the Financial Services sector (Asset Management)
- Market cap: 284.56M
- Current price: $91.70
- 52-week range: $64.60 - $94.06
- P/E ratio: 22.57
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. Th...
Company Information
- CEO
- Sector
- Financial Services
- Industry
- Asset Management
- Employees
- N/A
Contact Information
- Address
- 3500 Lacey Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.6)
✓ Lower volatility stock (Beta: 0.79) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Invesco Biotechnology & Genome ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for Invesco Biotechnology & Genome ETF
- ⚠Investors should consider how Invesco Biotechnology & Genome ETF fits within their overall portfolio allocation
Market Cap
284.56M
P/E Ratio (TTM)
22.57
Beta
0.79
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare PBE with peer companies:
- Price
- $80.29+0.16% (1D)
- Market cap
- 250.74M
- Price
- $33.58-0.36% (1D)
- Market cap
- 388.48M
- Price
- $72.34-2.48% (1D)
- Market cap
- 325.85M
- Price
- $45.57+1.82% (1D)
- Market cap
- 242.95M
- Price
- $37.88+0.17% (1D)
- Market cap
- 260.97M
- Price
- $49.49+0.58% (1D)
- Market cap
- 317.37M
- Price
- $87.67-0.58% (1D)
- Market cap
- 361.82M
- Price
- $57.55+2.49% (1D)
- Market cap
- 324.02M
- Price
- $31.61+1.84% (1D)
- Market cap
- 248.57M
- Price
- $60.36+1.65% (1D)
- Market cap
- 251.13M
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.
Financial Services (1D)
98/100 ⭐⭐⭐⭐⭐
- Overall
- +2.2%
- NYSE
- +2.6%
- NASDAQ
- +1.8%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +5.7% | +6.1% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | +2.9% | +4.3% | 22.2 | 86/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +3.3% | +3.5% | 24.1 | 80/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.1% | -0.2% | 25.2 | 56/100⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.7% | +1.2% | 29.7 | 56/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | -0.1% | -1.6% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -5.8% | -5.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | -3.0% | -5.9% | 26.8 | 28/100⭐⭐ |
| Industrials | +0.6% | +1.7% | -11.2% | 30.1 | 26/100⭐⭐ |
| Consumer Cyclical | +0.5% | -0.4% | -6.3% | 43.0 | 21/100⭐ |
| Technology | +0.6% | -2.3% | -9.6% | 40.7 | 17/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.